MoonLake Immunotherapeutics (MLTX)

Track

Stock chart
Ticker: MLTX Exchange: NAS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-10-08 2024-10-04 S Sale

BVF PARTNERS L P/IL

Non-Executive Director Large shareholder
132,549 -9.3%
50.00
USD 6,627,662 		132,549 -9.3% 50.00 USD 6,627,662
2024-10-08 2024-10-04 S Sale

BVF PARTNERS L P/IL

Non-Executive Director Large shareholder
836,862 -9.3%
50.00
USD 41,844,439 		836,862 -9.3% 50.00 USD 41,844,439
2024-10-08 2024-10-04 S Sale

BVF PARTNERS L P/IL

Non-Executive Director Large shareholder
1,030,589 -9.1%
50.00
USD 51,531,099 		1,030,589 -9.1% 50.00 USD 51,531,099
2024-10-08 2024-10-04 S Sale

Sturge Simon

Non-Executive Director
171,000 -49.9%
53.72
USD 9,186,120 		171,000 -49.9% 53.72 USD 9,186,120
2024-02-29 2024-02-29 PS Planned sale

Santos da Silva Jorge

Chief Executive Officer

Executive Director
4,740 -0.2%
55.89
USD 264,919 		4,740 -0.2% 55.89 USD 264,919
2024-02-29 2024-02-28 PS Planned sale

Reich Kristian

Chief Scientific Officer

Officer
28,090 -40.1%
55.00
USD 1,544,950 		28,090 -40.1% 55.00 USD 1,544,950
2024-02-29 2024-02-28 PS Planned sale

Reich Kristian

Chief Scientific Officer

Officer
31,910 -1.1%
55.00
USD 1,755,050 		31,910 -1.1% 55.00 USD 1,755,050
2024-02-29 2024-02-28 PS Planned sale

Santos da Silva Jorge

Chief Executive Officer

Executive Director
56,065 -1.8%
55.00
USD 3,083,575 		56,065 -1.8% 55.00 USD 3,083,575
2024-02-29 2024-02-27 PS Planned sale

Reich Kristian

Chief Scientific Officer

Officer
29,431 -29.6%
55.00
USD 1,618,705 		29,431 -29.6% 55.00 USD 1,618,705
2024-02-29 2024-02-27 PS Planned sale

Reich Kristian

Chief Scientific Officer

Officer
29,491 -1.0%
55.00
USD 1,622,005 		29,491 -1.0% 55.00 USD 1,622,005
2024-02-29 2024-02-27 PS Planned sale

Santos da Silva Jorge

Chief Executive Officer

Executive Director
62,810 -2.0%
55.00
USD 3,454,550 		62,810 -2.0% 55.00 USD 3,454,550
2024-02-23 2024-02-21 PS Planned sale

Santos da Silva Jorge

Chief Executive Officer

Executive Director
1,125 -0.0%
55.27
USD 62,179 		1,125 -0.0% 55.27 USD 62,179
2024-02-22 2024-02-21 PS Planned sale

Reich Kristian

Chief Scientific Officer

Officer
569 -0.6%
55.30
USD 31,466 		569 -0.6% 55.30 USD 31,466
2024-02-22 2024-02-21 PS Planned sale

Reich Kristian

Chief Scientific Officer

Officer
509 -0.0%
55.31
USD 28,153 		509 -0.0% 55.31 USD 28,153
2024-02-22 2024-02-20 PS Planned sale

Reich Kristian

Chief Scientific Officer

Officer
10,000 -9.1%
57.43
USD 574,300 		10,000 -9.1% 57.43 USD 574,300
2024-02-22 2024-02-20 PS Planned sale

Reich Kristian

Chief Scientific Officer

Officer
10,000 -0.3%
57.45
USD 574,500 		10,000 -0.3% 57.45 USD 574,500
2024-02-20 2024-02-20 PS Planned sale

Santos da Silva Jorge

Chief Executive Officer

Executive Director
20,000 -0.6%
57.44
USD 1,148,800 		20,000 -0.6% 57.44 USD 1,148,800
2024-02-20 2024-02-16 PS Planned sale

Santos da Silva Jorge

Chief Executive Officer

Executive Director
20,000 -0.6%
60.15
USD 1,203,000 		20,000 -0.6% 60.15 USD 1,203,000
2024-02-16 2024-02-16 PS Planned sale

Reich Kristian

Chief Scientific Officer

Officer
10,000 -8.3%
60.15
USD 601,500 		10,000 -8.3% 60.15 USD 601,500
2024-02-16 2024-02-16 PS Planned sale

Reich Kristian

Chief Scientific Officer

Officer
10,000 -0.3%
60.15
USD 601,500 		10,000 -0.3% 60.15 USD 601,500
// ... existing code ...